Mainz Biomed N.V. (MYNZ) Company Profile & Statistics

Mainz Biomed N.V.
MYNZ
(Nasdaq - US)
N/A
0.70
+0.04 (+5.91%)
in:usd•As of: May 13, 2024 10:18 UTC -4
Open
0.67
High
0.70
Low
0.67

About Mainz Biomed N.V.

CEO

Guido Baechler

Headquarters

robert koch strasse 50

mainz, 2m 55129, germany

Auditor

Reliant CPA PC

Employees

Share Holders

Website

www.mainzbiomed.com

Industry

biotechnology

Sector

health technology

Company Overview

Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.

Mainz Biomed N.V. Statistics

Valuation Measures

Market Capitalization ²	N/A
Enterprise Value	N/A
Enterprise Value/EBITDA (ttm)	N/A
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.44
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	56.51%
Operating Margin (ttm)	-2934.82%
Profit Margin (ttm)	-2954.80%
Return on Equity (ttm)	-488.05%
Return on Invested Capital (ttm)	-426.94%
Return on Assets (ttm)	-145.77%

Income Statement

Revenue (ttm)	895.50K
Revenue Per Share (ttm)	0.04
Gross Profit (ttm)	509.60K
EBITDA (ttm)³	-25.78M
Net Income Avi to Common (ttm)	-26.30M
Diluted EPS (ttm)	-1.64

Share Statistics

Beta (5Y Monthly)	0.28
52-Week Change	-87.27%
S&P500 52-Week Change	26.35%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	21.17M
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	N/A
% Held by Institutions	0.00%

Balance Sheet

Total Cash (mrq)	7.07M
Total Cash Per Share (mrq)	0.33
Total Debt (mrq)	6.39M
Total Debt/Equity (mrq)	196.68%
Current Ratio (mrq)	0.97%
Quick Ratio (mrq)	0.91%
Book Value Per Share (mrq)	0.15

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.35
Free Cash Flow (ytd)	-23.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Mainz Biomed N.V.

Trade With A Regulated Broker